Termination of Agreement for Rifamycin SV MMX with Dr. Falk Pharma

04.09.2023 - Cosmo Pharmaceuticals N.V. / Key word(s): Agreement Termination of Agreement for Rifamycin SV MMX with Dr. Falk Pharma 04.09.2023 / 05:45 GMT/BST Dublin, Ireland – 4 September 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) ...

Related Keywords

Switzerland ,Ireland ,Paris ,France General ,France ,Dublin ,Geneva ,Genè ,Swiss ,Hazel Winchester ,Sir John Rogerson ,Uceris Cortiment ,Lialda Mezavant Mesavancol ,John Rogerson ,Swiss Exchange ,Multi Matrix Technology ,Cosmo Pharmaceuticals ,Medtronic ,News Service ,Traveler Diarrhea ,London Healthcare Conference ,Communication European Midcap Event ,Cosmo Pharmaceuticals Aktie ,